Zyomyx

HIV diagnostics

Zyomyx, a private biotechnology company, specializes in HIV CD4 diagnostics.
  • Domain
  • Investment type
    Debt
  • Status
    Exit
  • Initial investment
    Series D-2
  • Partnered in
    2011
  • Headquarters
    USA
  • Program strategy
    Diagnostics

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.